Crossref

1.

2. Effects of adjuvants (granulocyte-macrophage colony-stimulating factor, levamisole, adjuvant system 04, adjuvant system 02B) on enhancing immune response to hepatitis B vaccine: a systematic review and meta-analysis

- Masood Zangi

- Seyedeh Yasaman Alemohammad

- Kosar Kohandel

- Sara Binaei

- Arian Tavasol

- Mobina Fathi

- Miremad Moafi Madani

- Niloofar Omidan

- Jasem Mohammadi

- Farajolah Maleki

3. Effectiveness of oral levamisole as an adjuvant to hepatitis B vaccination in healthcare workers non-responsive to previous vaccination: A randomized controlled trial

- Babak Sayad

- Armin Vazirian

- Arezoo Bozorgomid

- Nazanin Sayad

- Alireza Janbakhsh

- Mandana Afsharian

- Feizollah Mansouri

- Siavash Vaziri

- Shahab Rezaeian

- Maryam Gholizadeh

4. Hepatitis B vaccination for reducing morbidity and mortality in persons with HIV infection

- Mbah P Okwen

- Savanna Reid

- Basile Njei

- Lawrence Mbuagbaw

5. Clinical characteristics of COVID-19 patients with HIV coinfection in Wuhan, China

- Rongrong Yang

- Xien Gui

- Yongxi Zhang

- Yong Xiong

- Shicheng Gao

- Hengning Ke

6. Combining locoregional CAR-T cells, autologous + allogeneic tumor lysate vaccination and levamisole in treatment of glioblastoma

- Meric A. Altinoz

- Alp Ozpinar

- Emily Hacker

- Aysel Ozpinar

7. Novel insights on the therapeutic effect of levamisole on the chronic toxoplasmosis in mice model

- Hager S. Zoghroban

- Basma M. Elmansory

- Yasmine Amr Issa

- Amira K. Eltokhy

- Hend S. Abo Safia

- Gamal M. El Maghraby

- Amina M. Salama